Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawińskiego 5a, 02-106, Warsaw, Poland.
Laboratory of Chemical Biology, University of Wrocław, Poland.
Angew Chem Int Ed Engl. 2016 Jul 11;55(29):8235-8. doi: 10.1002/anie.201511968. Epub 2016 May 30.
Aβ4-42 is a major species of Aβ peptide in the brains of both healthy individuals and those affected by Alzheimer's disease. It has recently been demonstrated to bind Cu(II) with an affinity approximately 3000 times higher than the commonly studied Aβ1-42 and Aβ1-40 peptides, which are implicated in the pathogenesis of Alzheimer's disease. Metallothionein-3, a protein considered to orchestrate copper and zinc metabolism in the brain and provide antioxidant protection, was shown to extract Cu(II) from Aβ1-40 when acting in its native Zn7 MT-3 form. This reaction is assumed to underlie the neuroprotective effect of Zn7 MT-3 against Aβ toxicity. In this work, we used the truncated model peptides Aβ1-16 and Aβ4-16 to demonstrate that the high-affinity Cu(II) complex of Aβ4-16 is resistant to Zn7 MT-3 reactivity. This indicates that the analogous complex of the full-length peptide Cu(Aβ4-42) will not yield copper to MT-3 in the brain, thus supporting the concept of a physiological role for Aβ4-42 as a Cu(II) scavenger in the synaptic cleft.
Aβ4-42 是健康个体和阿尔茨海默病患者大脑中 Aβ 肽的主要物种。最近的研究表明,它与 Cu(II) 的亲和力比通常研究的 Aβ1-42 和 Aβ1-40 肽高约 3000 倍,而 Aβ1-40 和 Aβ1-40 肽与阿尔茨海默病的发病机制有关。金属硫蛋白-3(MT-3)是一种被认为在大脑中协调铜和锌代谢并提供抗氧化保护的蛋白质,当以其天然 Zn7 MT-3 形式存在时,它被证明可以从 Aβ1-40 中提取 Cu(II)。据推测,这种反应是 Zn7 MT-3 对 Aβ 毒性的神经保护作用的基础。在这项工作中,我们使用截断的模型肽 Aβ1-16 和 Aβ4-16 证明了 Aβ4-16 的高亲和力 Cu(II) 络合物对 Zn7 MT-3 的反应具有抗性。这表明全长肽 Cu(Aβ4-42)的类似络合物不会将铜释放到大脑中的 MT-3 中,从而支持 Aβ4-42 在突触小间隙中作为 Cu(II) 清除剂的生理作用的概念。